These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22605671)

  • 1. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.
    Cao P; Zhou L; Zhang J; Zheng F; Wang H; Ma D; Tian J
    Head Neck; 2013 May; 35(5):720-8. PubMed ID: 22605671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
    Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck.
    Odar K; Boštjančič E; Gale N; Glavač D; Zidar N
    Histopathology; 2012 Aug; 61(2):257-65. PubMed ID: 22690848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of miR-145 in human laryngeal squamous cell carcinoma.
    Karatas OF; Yuceturk B; Suer I; Yilmaz M; Cansiz H; Solak M; Ittmann M; Ozen M
    Head Neck; 2016 Feb; 38(2):260-6. PubMed ID: 26083661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profiles in supraglottic carcinoma.
    Zhang T; Han G; Wang Y; Chen K; Sun Y
    Oncol Rep; 2014 May; 31(5):2029-34. PubMed ID: 24676647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MicroRNAs regulate epithelial-mesenchymal transition of supraglottic laryngeal cancer].
    Tai J; Xiao X; Huang ZG; Yu ZK; Chen XH; Zhou WG; Chen XJ; Rao YS; Fang JG; Ni X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jun; 48(6):499-503. PubMed ID: 24103175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA profile in site-specific head and neck squamous cell cancer.
    Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
    Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.
    Shuang Y; Li C; Zhou X; Huang Y; Zhang L
    Oncol Rep; 2017 Oct; 38(4):2155-2165. PubMed ID: 28791411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of mir-21 and mir-375 in laryngeal squamous cell carcinoma].
    Hu A; Jin X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):788-92. PubMed ID: 23259291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
    Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
    Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
    Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
    Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-B-crystallin expression in human laryngeal squamous cell carcinoma tissues.
    Yilmaz M; Karatas OF; Yuceturk B; Dag H; Yener M; Ozen M
    Head Neck; 2015 Sep; 37(9):1344-8. PubMed ID: 24817638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
    Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
    Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.